We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Vertex Pharmaceuticals Incorporated
82 own
50 watching
Current Price
$332.58
$7.93
(2.44%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
85,642.6M
52-Week High
354.46
52-Week Low
243.17
Average Volume
1.45M
Dividend Yield
--
P/E Ratio
23.0149
Market Capitalization85,642.6M52-Week High354.4652-Week Low243.17Average Volume1.45MDividend Yield--P/E Ratio23.0149What does the Vertex Pharmaceuticals Incorporated do?
Vertex Pharmaceuticals Incorporated discovers, develops, manufactures, and commercializes medicines for serious diseases. The company focuses on developing and commercializing therapies for the treatment of cystic fibrosis (CF) and advancing its research and development programs. It markets ORKAMBI (lumacaftor in combination with ivacaftor) for the treatment of patients with CF 12 years of age and older who have two copies (homozygous) of the F508del mutation in their cystic fibrosis transmembrane conductance regulator (CFTR) gene; and KALYDECO (ivacaftor) for the treatment of patients with CF 2 years of age and older who have the G551D mutation or other specified mutations in their CFTR gene. The company also develops Tezacaftor (VX-661), a corrector compound that is in a Phase III development program in combination with ivacaftor in multiple CF patients; VX-152 and VX-440 that are CFTR corrector compounds in Phase II clinical trials, as well as VX-659 and VX-445 that are CFTR corrector compounds in Phase I clinical trials; and VX-371, an investigational epithelial sodium channel, which is in a Phase II development program. In addition, it engages in the research and mid-and early-stage development programs in the areas of oncology, pain, and neurology. The company sells its products primarily to specialty pharmacy providers and wholesalers in North America, as well as government-owned and supported customers internationally. Vertex Pharmaceuticals Incorporated has collaborations with Cystic Fibrosis Foundation Therapeutics Incorporated; Parion Sciences, Inc.; CRISPR Therapeutics AG; Moderna Therapeutics, Inc.; BioAxone Biosciences, Inc.; Merck KGaA; and Janssen Pharmaceuticals, Inc. The company was founded in 1989 and is headquartered in Boston, Massachusetts.
Read More
How much money does Vertex Pharmaceuticals Incorporated make?
News & Events about Vertex Pharmaceuticals Incorporated.
Stock Options Channel
1month ago
Investors in Vertex Pharmaceuticals, Inc. (VRTX) saw new options begin trading today, for the June 23rd expiration...
Fool.com Headlines
1month ago
Vertex dominates the cystic fibrosis market today.Vertex Pharmaceuticals (NASDAQ: VRTX) is the global leader in cystic fibrosis (CF) treatment. The company is known for its combination therapies targeting a defective protein that causes the disease's devastating symptoms.But one possible threat to ...
Business Wire
1month ago
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) approved the expanded use of TRIKAFTA (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to include children with cystic fibrosis (CF) ages 2 through 5 years who have at least one F508del...
Fool.com Headlines
1month ago
These companies are top players in their fields.When you think of healthcare stocks, you may think of steady growth and security. That's true in many instances. But healthcare players -- even some with that steady growth and security -- can also offer you a good deal of growth. And this may help you...
PR Newswire
1month ago
VERTEX DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Vertex To Contact Him Directly To Discuss Their Options VERTEX DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered...
Frequently Asked Questions
Frequently Asked Questions
What is Vertex Pharmaceuticals Incorporated share price today?
Can Indians buy Vertex Pharmaceuticals Incorporated shares?
How can I buy Vertex Pharmaceuticals Incorporated shares from India?
Can Fractional shares of Vertex Pharmaceuticals Incorporated be purchased?
What are the documents required to start investing in Vertex Pharmaceuticals Incorporated stocks?
What is today’s traded volume of Vertex Pharmaceuticals Incorporated?
What is today’s market capitalisation of Vertex Pharmaceuticals Incorporated?
What is the 52-Week High and Low Range of Vertex Pharmaceuticals Incorporated?
What percentage is Vertex Pharmaceuticals Incorporated down from its 52-Week High?
What percentage is Vertex Pharmaceuticals Incorporated up from its 52-Week Low?
Current Price
$332.58
$7.93
(2.44%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.